Amoxillin- and pefloxacin-induced cholesterogenesis and phospholipidosis in rat tissues
Open Access
- 21 February 2015
- journal article
- research article
- Published by Springer Nature in Lipids in Health and Disease
- Vol. 14 (1) , 1-17
Abstract
To investigate whether amoxillin and pefloxacin perturb lipid metabolism. Rats were treated with therapeutic doses of each antibiotic for 5 and 10 days respectively. Twenty four hours after the last antibiotic treatment and 5 days after antibiotic withdrawal, blood and other tissues (liver, kidney, brain, heart and spleen) were removed from the animals after an overnight fast and analysed for their lipid contents. Both antibiotics produced various degrees of compartment-specific dyslipidemia in the animals. While plasma and erythrocyte dyslipidemia was characterised by up-regulation of the concentrations of the major lipids (cholesterol, triglycerides, phospholipids and free fatty acids), hepatic and renal dyslipidemia was characterised by cholesterogenesis and phospholipidosis. Splenic dyslipidemia was characterised by cholesterogenesis and decreased phospholipid levels. Cardiac and brain cholesterol contents were not affected by the antibiotics. A transient phospholipidosis was observed in the brain whereas cardiac phospholipids decreased significantly. Lipoprotein abnormalities were reflected as down-regulation of HDL cholesterol. Furthermore, the two antibiotics increased the activity of hepatic HMG-CoA reductase. Although erythrocyte phospholipidosis was resolved 5 days after withdrawing the antibiotics, dyslipidemia observed in other compartments was still not reversible. Our findings suggest that induction of cholesterogenesis and phospholipidosis might represent additional adverse effects of amoxillin and pefloxacin.Keywords
This publication has 44 references indexed in Scilit:
- Hypolipidemic effects of lactic acid bacteria fermented cereal in ratsLipids in Health and Disease, 2012
- Tissue dyslipidemia in salmonella-infected rats treated with amoxillin and pefloxacinLipids in Health and Disease, 2012
- Lead-induced phospholipidosis and cholesterogenesis in rat tissuesChemico-Biological Interactions, 2009
- HDL cholesterol levels are an important factor for determining the lifespan of erythrocytesExperimental Hematology, 2005
- Antimicrobial Safety: Focus on FluoroquinolonesClinical Infectious Diseases, 2005
- A Toxicogenomic Approach to Drug-Induced Phospholipidosis: Analysis of Its Induction Mechanism and Establishment of a Novel in Vitro Screening SystemToxicological Sciences, 2004
- Comparative Tolerability of the Newer Fluoroquinolone AntibacterialsDrug Safety, 1999
- Cationic Amphiphilic Drug-Induced PhospholipidosisToxicologic Pathology, 1997
- Regulation of Cellular Cholesterol Efflux by Lecithin:Cholesterol Acyltransferase Reaction through Nonspecific Lipid ExchangeJournal of Biological Chemistry, 1996
- Regulation of Short‐Term Changes in Hepatic β‐Hydroxy‐β‐methylglutaryl‐CoA Reductase ActivityEuropean Journal of Biochemistry, 1982